AN INVESTIGATION OF THE COEXISTENCE OF ABNORMAL INVOLUNTARY MOVEMENTS, PARKINSONISM, AND AKATHISIA IN CHRONIC PSYCHIATRIC-INPATIENTS

被引:0
|
作者
KUCHARSKI, LT
WAGNER, RL
FRIEDMAN, JH
机构
[1] RHODE ISL MED CTR,RHODE ISL PSYCHIAT RES & TRAINING CTR,POB 8269,CRANSTON,RI 02920
[2] BROWN UNIV,PROGRAM MED,DEPT PSYCHIAT & HUMAN BEHAV,PROVIDENCE,RI 02912
[3] BROWN UNIV,PROGRAM MED,DEPT MED,DIV NEUROL,PROVIDENCE,RI 02912
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:215 / 217
页数:3
相关论文
共 31 条
  • [21] PREVALENCE OF PERSISTENT ABNORMAL INVOLUNTARY MOVEMENTS AMONG PATIENTS IN A NIGERIAN LONG-STAY PSYCHIATRIC UNIT
    ODEJIDE, AO
    INTERNATIONAL PHARMACOPSYCHIATRY, 1980, 15 (05): : 292 - 300
  • [22] MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism
    Paquette, Melanie A.
    Anderson, Akari M.
    Lewis, Jason R.
    Meshul, Charles K.
    Johnson, Steven W.
    Berger, S. Paul
    NEUROPHARMACOLOGY, 2010, 58 (07) : 1002 - 1008
  • [23] AGING AND INTELLECTUAL IMPAIRMENT IN CHRONIC-SCHIZOPHRENIA - RELATIONSHIP TO ABNORMAL INVOLUNTARY MOVEMENTS (TARDIVE-DYSKINESIA)
    WADDINGTON, J
    YOUSSEF, HA
    IRISH JOURNAL OF MEDICAL SCIENCE, 1986, 155 (01) : 26 - 26
  • [24] IS DILTIAZEM EFFECTIVE IN TREATING THE SYMPTOMS OF (TARDIVE) DYSKINESIA IN CHRONIC PSYCHIATRIC-INPATIENTS - A NEGATIVE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    LOONEN, AJM
    VERWEY, HA
    ROELS, PR
    VANBAVEL, LP
    DOORSCHOT, CH
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1992, 12 (01) : 39 - 42
  • [25] INTERACTION OF CHANGES IN HOSPITAL ENVIRONMENT AND NEUROTROPIC CO-MEDICATION IN CHRONIC PSYCHIATRIC-INPATIENTS - A PLACEBO CONTROLLED DOUBLE-BLIND-STUDY
    LEHMANN, E
    KRETSCHMAR, JH
    BRAUER, H
    REINHARDT, B
    PHARMACOPSYCHIATRIA, 1982, 15 (02): : 57 - 60
  • [26] Effect of the mGlu2/3 orthosteric agonist LY-404,039 on abnormal involuntary movements and parkinsonism in the 6-OHDA-lesioned rat
    Kang, W.
    Frouni, I.
    Kwan, C.
    Desbiens, L.
    Bedard, D.
    Hamadjida, A.
    Huot, P.
    MOVEMENT DISORDERS, 2021, 36 : S215 - S215
  • [27] Positive association between striatal serotonin level and abnormal involuntary movements in chronic L-DOPA-treated hemiparkinsonian rats
    Gil, Suk J.
    Park, Chang H.
    Lee, Jeong E.
    Minn, Yang K.
    Koh, Hyun C.
    BRAIN RESEARCH BULLETIN, 2011, 84 (02) : 151 - 156
  • [28] Interactive effect of cytochrome P450 17α-hydroxylase and dopamine D3 receptor gene polymorphisms on abnormal involuntary movements in chronic schizophrenia
    Segman, RH
    Heresco-Levy, U
    Yakir, A
    Goltser, T
    Strous, R
    Greenberg, DA
    Lerer, B
    BIOLOGICAL PSYCHIATRY, 2002, 51 (03) : 261 - 263
  • [29] Age and the relationship of dopamine D3, serotonin 2C and serotonin 2A receptor genes to abnormal involuntary movements in chronic schizophrenia
    Segman, RH
    Lerer, B
    MOLECULAR PSYCHIATRY, 2002, 7 (02) : 137 - 139
  • [30] Age and the relationship of dopamine D3, serotonin 2C and serotonin 2A receptor genes to abnormal involuntary movements in chronic schizophrenia
    R H Segman
    B Lerer
    Molecular Psychiatry, 2002, 7 : 137 - 139